We are monitoring the impact of COVID-19 on Latin America Cancer Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1347
Share on
Share on

Latin America Cancer Vaccines Market Research Report – Segmented By Treatment Type, Cancer Type, Vaccine Type, End User & Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1347
Pages: 145

The size of the Latin American Cancer Vaccines Market was worth USD 0.55 billion in 2021 and estimated to reach USD 1.24 billion by the end of 2026, hiking at a CAGR of 17.52% between 2021 to 2026.  

Cancer vaccines are one of the revolutionary innovations that could relieve the pains and sufferings from cancer. Therapeutic cancer vaccines target treating of existing cancer by boosting the immune system to fight against tumors associated with antigens. Presently, the size of the therapeutic cancer vaccine market is much smaller if compared to other therapeutics. But this continuous trend is going to vary with increasing research and development. Researchers have developed and designed very powerful monoclonal antibodies, which are attached along with the drugs to make it more effective.

The key drivers of Latin America cancer vaccines market are rising number of people with cancer, increasing public awareness of vaccines, smoking and excessive alcoholic intake, presence of strong late-stage pipeline Vaccines, vendors' patient-assistance programs are the major factors driving the growth of the market. stringent regulations for the approval, Vaccines costs are the factors limiting the growth of the market.

Based on Cancer type, the Latin America market is segmented into Prostate, Cervical, Anal, Throat, and others. Based on Vaccine type, the market is segmented into Protein and Peptide based , Tumour cell, Dendritic cell, Genetic vaccines and Others. Based on End Users, the market is segmented into Cancer Treatment Centres and Research Institutes. Based on Geography, Latin America Cancer Vaccines Therapeutics market is analysed under various regions namely Brazil, Argentina, and Mexico.

Major players dominating the Latin America cancer vaccines market are Dendreon, GlaxoSmithKline and Merck. Companies with their products in pipeline are Aduro Biotech, Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian  Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio Pharmaceuticals, ISA Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest Biotherapeutics, NovaRx,  OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Sotio, Transgene, Ubivac, Vaccinogen, Vaxon Biotech.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology Data                   

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Treatment type                        

                                5.1.1 Prophylactic           

                                5.1.2 Therapeutic            

                                5.1.3 Y-o-Y Growth Analysis, By Cancer Type       

                                5.1.4 Market Attractiveness Analysis, By Cancer type      

                                5.1.5 Market Share Analysis, By Cancer Type       

                5.2 Cancer Type               

                                5.2.1 Introduction           

                                5.2.2 Prostate Cancer    

                                5.2.3 Cervical Cancer     

                                5.2.4 Colorectal Cancer 

                                5.2.5 Throat Cancer        

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Cancer Type       

                                5.2.8 Market Attractiveness Analysis, By Cancer type      

                                5.2.9 Market Share Analysis, By Cancer Type       

                5.3 Vaccine Type                             

                                5.3.1 Introduction           

                                5.3.2 Tumour cell Vaccines          

                                5.3.3 Protein or Peptide Vaccines            

                                5.3.4 Genetic Vaccines  

                                                5.3.4.1 DNA Vaccines

                                                5.3.4.2 RNA Vaccines

                                5.3.5 Dendritic cell Vaccines       

                                5.3.6 other Vaccines      

                                5.3.7 Y-o-Y Growth Analysis, By Vaccine Type     

                                5.3.8 Market Attractiveness Analysis, By Vaccine Type    

                                5.3.9 Market Share Analysis, By Vaccine Type     

                5.4 End Users                   

                                5.4.1 Introduction           

                                5.4.2 Cancer Treatment Centers

                                5.4.3 Research Institutes             

                                5.4.4 Y-o-Y Growth Analysis, By End User              

                                5.4.5 Market Attractiveness Analysis, By End User            

                                5.4.6 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment Type

                                                6.1.3.3 By Cancer Type

                                                6.1.3.4 By Vaccine Type

                                                6.1.3.5 By End User

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment Type

                                                6.1.4.3 By Cancer Type

                                                6.1.4.4 By Vaccine Type

                                                6.1.4.5 By End User

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment Type

                                                6.1.5.3 By Cancer Type

                                                6.1.5.4 By Vaccine Type

                                                6.1.5.5 By End User

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Merck & co                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Dendreon                   

                8.3 Glaxosmithkline                       

                8.4 AstraZeneca plc                        

                8.5 Aduro BioTech                          

                8.6 MedImmune                             

                8.7 Sanofi                           

                8.8 Galena Biopharma                   

                8.9 Ubivac                          

                8.10 Oxford Biomedica                 

                8.11 Immunofrontier Inc                              

                8.12 Oncovir Inc                               

                8.13 Immune Cell Therapy (ICT)                

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Cancer Vaccines Market, By Treatment Type, From 2021 to 2026 (USD Million)
  2. Latin America Prophylactic Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Therapeutic Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Cancer Vaccines Market, By Cancer Type, From 2021 to 2026 (USD Million)
  5. Latin America Prostate Cancer Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  6. Latin America Cervical Cancer Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Colorectal Cancer Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  8. Latin America Throat Cancer Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  9. Latin America Cancer Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  10. Latin America Tumour cell Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  11. Latin America Protein or Peptide Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  12. Latin America Genetic Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  13. Latin America Dendritic cell Vaccines Market, By Region, From 2021 to 2026 (USD Million)
  14. Latin America Cancer Vaccines Market, By End User , From 2021 to 2026 (USD Million)
  15. Latin America Cancer Treatment Centers' Vaccine Usage Market, By Region, From 2021 to 2026 (USD Million)
  16. Latin America Research Institutes' Vaccine Usage Market, By Region, From 2021 to 2026 (USD Million)
  17. Brazil Cancer Vaccines Market, By Treatment Type, From 2021 to 2026 (USD Million)
  18. Brazil Cancer Vaccines Market, By Cancer Type, From 2021 to 2026 (USD Million)
  19. Brazil Cancer Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  20. Brazil Cancer Vaccines Market, By End User , From 2021 to 2026 (USD Million)
  21. Argentina Cancer Vaccines Market, By Treatment Type, From 2021 to 2026 (USD Million)
  22. Argentina Cancer Vaccines Market, By Cancer Type, From 2021 to 2026 (USD Million)
  23. Argentina Cancer Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  24. Argentina Cancer Vaccines Market, By End User , From 2021 to 2026 (USD Million)
  25. Mexico Cancer Vaccines Market, By Treatment Type, From 2021 to 2026 (USD Million)
  26. Mexico Cancer Vaccines Market, By Cancer Type, From 2021 to 2026 (USD Million)
  27. Mexico Cancer Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  28. Mexico Cancer Vaccines Market, By End User , From 2021 to 2026 (USD Million)
  29. Rest of Latin America Cancer Vaccines Market, By Treatment Type, From 2021 to 2026 (USD Million)
  30. Rest of Latin America Cancer Vaccines Market, By Cancer Type, From 2021 to 2026 (USD Million)
  31. Rest of Latin America Cancer Vaccines Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  32. Rest of Latin America Cancer Vaccines Market, By End User , From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample